16th Apr 2020 15:07
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Said Darwazah |
2 | Reason for the notification | |
a) | Position/status | Executive Chairman |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C. |
c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 36,438 |
d) | Aggregated information | N/A |
e) | Date of the transaction | 15 April 2020 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Mazen Darwazah
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Mazen Darwazah |
2 | Reason for the notification | |
a) | Position/status | Executive Vice Chairman |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C. |
c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 19,318 |
d) | Aggregated information | N/A |
e) | Date of the transaction | 15 April 2020 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Majda Labadi
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Majda Labadi |
2 | Reason for the notification | |
a) | Position/status | PDMR |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C. |
c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 16,146 |
d) | Aggregated information | N/A |
e) | Date of the transaction | 15 April 2020 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Riad Mishlawi
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Riad Mishlawi |
2 | Reason for the notification | |
a) | Position/status | PDMR |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C. |
c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 20,146 |
d) | Aggregated information | N/A |
e) | Date of the transaction | 15 April 2020 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Bassam Kanaan
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Bassam Kanaan |
2 | Reason for the notification | |
a) | Position/status | PDMR |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C. |
c) | Price(s) and volume(s) | Price(s): £22.82 Volume(s): 23,233 |
d) | Aggregated information | Number of Shares: 23,233 Price: £530,177 |
e) | Date of the transaction | 14 April 2020 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Khalid Nabilsi
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Khalid Nabilsi |
2 | Reason for the notification | |
a) | Position/status | PDMR |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Conditional Shares acquired from the grant made on 13 April 2017 and vested on 14 April 2020 under the 2014 EIP Element C. |
c) | Price(s) and volume(s) | Price(s): £22.82 Volume(s): 23,751 |
d) | Aggregated information | Number of Shares: 23,751 Price: £541,998 |
e) | Date of the transaction | 14 April 2020 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Susan Ringdal
a) | Name | Susan Ringdal | |||||||||||||||
2 | Reason for the notification | ||||||||||||||||
a) | Position/status | PDMR | |||||||||||||||
b) | Initial notification /Amendment | Initial notification | |||||||||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||||||||
a) | Name | Hikma Pharmaceuticals PLC | |||||||||||||||
b) | LEI | 549300BNS685UXH4JI75 | |||||||||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||||||||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 | |||||||||||||||
b) | Nature of the transaction
| Shares acquired from the exercise of nil-cost options granted on 17 May 2013 and 11 June 2014 under the 2007 LTIP and nil-cost options granted on 10 April 2015 under the 2014 EIP Elements B and C | |||||||||||||||
c) | Price(s) and volume(s) |
| |||||||||||||||
d) | Aggregated information | Number of Shares: 42,210 Price: £963,232 | |||||||||||||||
e) | Date of the transaction | 15 April 2020 | |||||||||||||||
f) | Place of the transaction | London Stock Exchange (XLON) | |||||||||||||||
Brian Hoffmann
a) | Name | Brian Hoffmann | |||||||||
2 | Reason for the notification | ||||||||||
a) | Position/status | PDMR | |||||||||
b) | Initial notification /Amendment | Initial notification | |||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||
a) | Name | Hikma Pharmaceuticals PLC | |||||||||
b) | LEI | 549300BNS685UXH4JI75 | |||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 | |||||||||
b) | Nature of the transaction
| Shares acquired from the vesting of nil-cost options granted on 11 May 2016 and 13 April 2017 under the 2014 EIP Element B. | |||||||||
c) | Price(s) and volume(s) |
| |||||||||
d) | Aggregated information | Number of Shares: 17,557 Price: £392,223 | |||||||||
e) | Date of the transaction | 16 April 2020 | |||||||||
f) | Place of the transaction | London Stock Exchange (XLON) | |||||||||
a) | Name | Brian Hoffmann |
2 | Reason for the notification | |
a) | Position/status | PDMR |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Disposal of Shares. |
c) | Price(s) and volume(s) | Price(s): £22.79 Volume(s): 2,219 |
d) | Aggregated information | Number of Shares: 2,219 Price: £50,571 |
e) | Date of the transaction | 14 April 2020 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Peter SpeirsCompany Secretary, responsible for releasing this announcement16 April 2020+44 (0) 20 7399 2760
Related Shares:
Hikma Pharmaceuticals